Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 25, 2018 Off

N4 Pharma presents Nuvec in Japan

By Dino Mustafić

N4 Pharma will present its Nuvec in a meeting with japanese companies in February. The UK pharmaceutical company will be…

Ablynx opens door for new scientific boss
January 24, 2018 Off

Ablynx opens door for new scientific boss

By Dino Mustafić

Belgian based drugmaker Ablynx has appointed Robert Friesen, PhD, as Chief Scientific Officer (CSO), who will begin his role in…

ImmuPharma cashes in £10M ($14.03M)
January 24, 2018 Off

ImmuPharma cashes in £10M ($14.03M)

By Dino Mustafić

ImmuPharma has completed a fundraise totalling £10 million (14.03million) before expenses by placing 6,944,445 new ordinary shares of 10p each…

Portola Pharmaceuticals to present late-breaker abstract on antidote for deadly bleeding patients
January 23, 2018 Off

Portola Pharmaceuticals to present late-breaker abstract on antidote for deadly bleeding patients

By Dino Mustafić

Portola Pharmaceuticals said that it will present an abstract about results from its trial in Phase 3b/4 of its investigational…

ProcureCon Pharma explains Analytical and Digital Procurement in Pharma
January 23, 2018 Off

ProcureCon Pharma explains Analytical and Digital Procurement in Pharma

By Dino Mustafić

Join ProcureCon Pharma to learn how to master Analytical and Digital Procurement in Pharma. Download agenda here: https://procureconhealthcare.wbresearch.com

U.S. FDA OK’s Baxter’s ready-to-use cardiovascular medication Bivalirudin
January 23, 2018 Off

U.S. FDA OK’s Baxter’s ready-to-use cardiovascular medication Bivalirudin

By Dino Mustafić

Baxter International has announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection…

Amgen’s and Novartis’s Aimovig reduces migraine days for people who failed to be rescued with earlier treatments, study shows
January 23, 2018 Off

Amgen’s and Novartis’s Aimovig reduces migraine days for people who failed to be rescued with earlier treatments, study shows

By Dino Mustafić

Amgen’s Phase 3b study called Liberty, in co-development with Novartis, aimed to test Aimovig for treating migraine, has met it’s…

Alexion Pharmaceuticals refreshes its board of directors
January 23, 2018 Off

Alexion Pharmaceuticals refreshes its board of directors

By Dino Mustafić

Alexion Pharmaceuticals has welcomed Deborah Dunsire, M.D. as the company’s Board of Directors new independent director. 

January 23, 2018 Off

Arena Pharmaceuticals to host talks about treatment of autoimmune diseases

By Dino Mustafić

Arena Pharmaceuticals ARNA), today announced that it will host a key opinion leader (KOL) event for investors focused on sphingosine-1-phosphate…

Novartis buys French radiopharmaceutical company AAA for $3.9 billion
January 22, 2018 Off

Novartis buys French radiopharmaceutical company AAA for $3.9 billion

By Dino Mustafić

Novartis Group France has completed a tender to buy Advanced Accelerator Applications S.A. for $3,9 billion, or $41.00 per ordinary…

Posts pagination

Previous 1 … 3,412 3,413 3,414 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine